(VIANEWS) – Shares of 10x Genomics (NASDAQ: TXG) rose by a staggering 25.61% in 14 days from $37.1 to $46.60 at 14:31 EST on Tuesday, after two consecutive sessions in a row of losses. NASDAQ is dropping 2.41% to $11,247.29, following the last session’s downward trend.
10x Genomics’s last close was $48.95, 76.58% below its 52-week high of $208.99.
Today’s last reported volume for 10x Genomics is 776838 which is 51.14% below its average volume of 1590020.
10x Genomics’s Sales
10x Genomics’s sales growth is 78.1% for the ongoing quarter and 33.2% for the next. The company’s growth estimates for the current quarter and the next is 70.8% and 97.2%, respectively.
10x Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.
10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 6.23%, a negative 0.42%, and a positive 5.02%, respectively.
10x Genomics’s highest amplitude of average volatility was 6.62% (last week), 5.74% (last month), and 5.02% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
10x Genomics’s stock is considered to be oversold (<=20).
10x Genomics’s Stock Yearly Top and Bottom Value
10x Genomics’s stock is valued at $46.60 at 14:31 EST, way under its 52-week low of $128.15.
10x Genomics’s Moving Average
10x Genomics’s worth is way below its 50-day moving average of $155.93 and way under its 200-day moving average of $170.12.
More news about 10x Genomics (TXG).